Opening book details…
About this Medicine article
Bleeding risk with AZD6140, a reversible P2Y12receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial by S. Husted; R. A. Harrington; C. P. Cannon; R. F. Storey; P. Mitchell; H. Emanuelsson is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- S. Husted; R. A. Harrington; C. P. Cannon; R. F. Storey; P. Mitchell; H. Emanuelsson
- Publisher
- John Wiley and Sons; Wiley (Blackwell Publishing); Wiley-Blackwell; Wiley (ISSN 1368-5031)
- Published
- 2009
- Field
- Medicine (Health Sciences)